newsfilter
← Latest News
GlobeNewswire·

ProMIS Neurosciences presents at the 2022 Neuro4D International Conference

TORONTO, Ontario and CAMBRIDGE, MA, May 17, 2022 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX:PMN) (OTCQB:ARFXF), a biotechnology company focused on the discovery and development of therapeutics targeting misfolded proteins such as toxic oligome